Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | -3.02% | 3.93% | 15.35% | -7.40% | 0.00% |
| Total Depreciation and Amortization | -2.02% | -42.94% | -45.09% | -42.51% | -42.44% |
| Total Amortization of Deferred Charges | 289.29% | 21,300.00% | -- | -- | -- |
| Total Other Non-Cash Items | -21.07% | -67.93% | -34.31% | -16.17% | 68.52% |
| Change in Net Operating Assets | -835.71% | 169.89% | -205.56% | 144.90% | 96.37% |
| Cash from Operations | -12.22% | 15.49% | -8.85% | 2.54% | 24.05% |
| Capital Expenditure | 0.00% | -- | -56.67% | 59.46% | 97.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 335.01% | -72.07% | -56.62% | -74.55% | 38.70% |
| Cash from Investing | 334.38% | -72.49% | -57.06% | -74.63% | 41.39% |
| Total Debt Issued | -- | -- | -- | 2,141.99% | -- |
| Total Debt Repaid | -1,896.92% | 33.17% | 14.38% | 85.15% | -- |
| Issuance of Common Stock | -100.00% | -97.87% | -98.04% | -99.20% | -94.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | -1,172.55% | -101.11% | -152.94% | 538.68% | -132.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.78% | -168.90% | -2,455.29% | 219.38% | 25.24% |